The purpose of this study is to determine if the combination of 2007RD01, a natural extract, and saw palmetto lipidic extract, is more effective at treating lower urinary tract symptoms associated with benign prostatic hyperplasia than saw palmetto lipidic extract alone.

Inclusion Criteria:

• Patient must be an adult man aged between 50 and 75
• Patient must have Benign Prostatic Hyperplasia symptoms

Exclusion Criteria:

• Patient has a malfunction of the urinary tract, is suffering from acute urinary retention, or is suffering from prostate cancer or urinary tract infection
• Patient has been subjected to surgery of the prostate, bladder or urethra
• Patient has taken a 5-alpha-reductase inhibitor in the 6-month period preceding screening
• Patient has taken an alpha-blocker in the 2-week period preceding screening